Vitamins & Supplements · Formula
Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric)
Joint-support supplement blends · also called Joint health formulas, glucosamine and chondroitin combinations, suplementos para las articulaciones
Joint formulas are capsules, tablets, powders or gummies that mix ingredients such as glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. They are sold for joint comfort and mobility. Almost all the research is on single ingredients in knee osteoarthritis, not on the blend you buy. Main cautions are liver injury with turmeric products and a blood-thinner interaction with glucosamine.
General information, not medical advice. Last substantive update · Not medically reviewed. A named clinician has not signed off on this page. How this page is made
About Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric)
Joint formulas are mixes of ingredients sold for joint comfort. Research is on single ingredients and pairs, mostly in knee osteoarthritis, with mixed or low-certainty results. Check the label and ask a pharmacist, especially if you take warfarin.
What joint formulas are
Joint formulas are dietary supplements that combine several ingredients in one capsule, tablet, powder or gummy. They are sold to adults, often older adults, who want help with joint comfort and movement.
They are not medicines. In the US, NCCIH says supplements are not approved by the FDA before they are sold, and makers are responsible for safety and labelling.
What is usually inside
The usual ingredients are glucosamine, chondroitin sulfate, MSM (methylsulfonylmethane), turmeric or curcumin extract and collagen. Some add boswellia, vitamins C and D, or omega-3. Each ingredient is covered on its own page linked under Related; MSM does not have its own page yet.
NCCIH says glucosamine is sold as glucosamine sulfate or glucosamine hydrochloride, and chondroitin as chondroitin sulfate, separately or together. In some other countries certain preparations are sold as prescription drugs.
Reading the label
A serving is the amount the label says to take. Check how many capsules or gummies make one serving, and compare amounts per serving rather than per bottle.
A proprietary blend lists a total weight for a group of ingredients but not each amount. That makes it hard to see whether a product holds the amounts used in trials. Gummies and capsules are different formats; see the gummies page for what each can carry. The sources read gave no Daily Value for glucosamine, chondroitin, MSM or curcumin, so a % Daily Value column will not help for those.
What the research shows
No trial tested a blend of glucosamine, chondroitin, MSM, turmeric and collagen together. The best evidence is on pairs and single ingredients. The large US trial of glucosamine and chondroitin was negative overall.
A few small trials of other mixes were positive, and turmeric, MSM and collagen each show short-term pain gains in small or low-quality reviews. These results cannot be added together: each tested a different product.
At a glance
Traditional uses history, not proof
- Sold for joint comfort and mobility
- Turmeric has traditional use for arthritis in Indian, Chinese, Islamic and Thai medicine
Studied for research
- Glucosamine plus chondroitin for knee osteoarthritis pain, mixed evidence
- Whole blends tested as one product, very low certainty
- Joint structure, low certainty
- Turmeric or curcumin alone, low certainty
- MSM alone, low certainty
- Collagen alone, low certainty
Main compounds
- Glucosamine
- Chondroitin sulfate
- MSM (methylsulfonylmethane)
- Curcuminoids
- Collagen
Common forms
- Capsules and tablets
- Powders
- Gummies and chewables
- Single-ingredient products
- Proprietary blends
Research links: 2006 trial (GAIT): glucosamine and chondroitin for knee pain, 1,583 people · 2016 trial (MOVES): glucosamine-chondroitin pair versus celecoxib · 2017 trial: glucosamine-chondroitin with and without MSM · 2018 review: dietary supplements for osteoarthritis, 69 trials · 2011 EFSA statement: glucosamine and blood thinners · Research Library · Genes & Biomarkers Library
What it is and its history
- Accepted scientific name
- Joint health formulas (glucosamine, chondroitin, MSM, turmeric and collagen blends)
- Common names
- Joint support supplements (English); Joint blends (English); Glucosamine and chondroitin combination (English); Suplementos para las articulaciones (Spanish); Fórmulas para la salud articular (Spanish)
- Family or group
- Multi-ingredient dietary supplement. Usual ingredients: glucosamine (sulfate or hydrochloride), chondroitin sulfate, MSM (methylsulfonylmethane), turmeric or curcumin extract and collagen (hydrolysed or undenatured type II). Some add boswellia, vitamins C and D, omega-3 or other extracts.
- Harvest and processing
- Not read from a source. NCCIH names the forms sold as glucosamine sulfate and glucosamine hydrochloride, and chondroitin sulfate. Turmeric supplements are made from the rhizome of Curcuma longa.
- Look-alikes and adulterants
- Name: Bone health formulas; Note: Calcium, vitamin D, K, magnesium and collagen mixes. Have their own page.; Name: Hair, skin and nails formulas; Note: Biotin and collagen mixes. Have their own page.; Name: Multi-collagen blends; Note: Collagen types I, II, III, V and X in one product. Has its own page.; Name: Prescription glucosamine or chondroitin sold as a drug in some countries; Note: NCCIH notes that in some other countries certain preparations are sold as prescription drugs.
- Sustainability and conservation
- Not assessed.
Traditional use and history history, not clinical proof
| Tradition or era | Documented use | Source |
|---|---|---|
| Chinese, Indian (Ayurvedic), Islamic and Thai traditional medicine (turmeric) | Turmeric has been used traditionally for indigestion, the common cold, skin infections, arthritis, abdominal pain and liver disease. | s-nccih-turmeric |
Traditional use shows how it was used. It does not show that it works or is safe today.
What is inside, and how it may work
What it contains and how those compounds act in cells and animals. Laboratory and animal mechanisms are not proven effects in people.
Main compounds
| Compound | Family | Where it is concentrated | Activity studied | Level of evidence |
|---|---|---|---|---|
| Glucosamine | amino sugar | Sold as glucosamine sulfate or glucosamine hydrochloride (NCCIH). | NCCIH: a building block for molecules that form part of cartilage structure. 15 4 | Human data |
| Chondroitin sulfate | glycosaminoglycan | Sold as chondroitin sulfate (NCCIH). | NCCIH: a component of cartilage that helps it resist compression. 15 4 | Human data |
| MSM (methylsulfonylmethane) | organic sulfur compound | Not read from a source. | Studied in two small knee osteoarthritis trials. 2 | Human data |
| Curcuminoids (curcumin) | plant polyphenols | NCCIH: oral curcumin products vary in how much curcumin they contain. | The compounds usually credited for turmeric's effects. Some products add piperine from black pepper to help absorption. 16 20 | Human data |
| Collagen (hydrolysed or undenatured type II) | protein | Not read from a source. | Studied as hydrolysed collagen and as undenatured type II collagen in osteoarthritis trials. 10 | Human data |
| Common add-ons seen in the blend trials | mixed | Boswellic acids, guava leaf extract, vitamins C and D, omega-3 and ibuprofen appear in individual blend trials read. | Each was tested only as part of one specific mix. 13 14 19 | Human data |
Mechanisms, receptors and pathways
| Target or pathway | Gene or receptor | What was found | Level |
|---|---|---|---|
| Cartilage building blocks (glucosamine, chondroitin) | Not specified in the sources read | NCCIH describes glucosamine and chondroitin as constituents of cartilage, and says it is still uncertain whether they help osteoarthritis symptoms or joint structure. 15 | Background statement from a regulator, not shown in people |
| Blood markers of cartilage breakdown and joint-lining inflammation | Not specified | In a 32-person pilot of a mixed product, blood C2C fell 10% and hyaluronan 25%, not statistically significant. 14 | Human (small, not significant) |
| Warfarin-processing liver enzymes | Liver CYP enzymes including (S)-warfarin hydroxylase | Glucosamine and chondroitin did not switch these enzymes up or down in mice. 21 | Animal research |
Absorption, metabolism and elimination
- Absorption
- Not read for these ingredients. NCCIH says turmeric and curcumin forms made to be absorbed better exist and have been linked to liver harm.
- Distribution
- Not found.
- Metabolism
- Not found for blends.
- Elimination
- Not found.
- Bioavailability
- Not compared across blends in the sources read.
Isolated compounds versus whole extracts
The trials tested particular products and salts. Results for glucosamine sulfate, glucosamine hydrochloride, a prescription preparation or a different blend cannot be carried over to another product. Turmeric as a food spice is not the same as a concentrated, high-absorption curcumin extract.
Nutritional composition
Not a food. Glucosamine, chondroitin and MSM are not nutrients with daily needs. No USDA or NIH food-content figures were read for these ingredients, so none are stated. Blends that also contain vitamins or minerals have official intake limits for those nutrients; none are stated here.
1 mixed findings4 low certainty1 very low certainty1 not enough evidence
What was looked at
The 7 benefits and uses checked for Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric), each with how strong the evidence is. Tap one to open it.
- Glucosamine plus chondroitin pairs and knee osteoarthritis painMixed findings
- Multi-ingredient joint blends tested as one productVery low certainty
- Joint structure (cartilage and joint space)Low certainty
- Turmeric or curcumin (one usual ingredient)Low certainty
- MSM (methylsulfonylmethane)Low certainty
- Collagen in the mix (hydrolysed or undenatured type II)Low certainty
- Other joints (hip, hand, jaw)Not enough evidence
Lab markers tracked in the studies
Knee pain score (WOMAC pain)Pain on a 0 to 10 style line (VAS)Joint space width on X-rayMRI cartilage and joint-lining swellingBlood markers of cartilage breakdown (C2C) and joint lining (hyaluronan)
What is Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric) good for?
What trials found for the blend type and for each usual ingredient, and how strong the human evidence is. Trials of one ingredient are listed separately and are not added together as if the mix had been tested.
Benefits, one by one
Each card is a research question, not a promise. Tap a goal to filter. Open a card to see the studies, doses and limits.
Glucosamine plus chondroitin pairs and knee osteoarthritis pain
Mixed findingsThe nearest thing to a tested joint blend is the glucosamine and chondroitin pair. The big US trial (GAIT, 1,583 people) found no clear pain benefit overall. A European trial found the pair did about as well as celecoxib, but it had no placebo group. Two years on, GAIT found no clinically important difference.
5 studiesThese trials tested glucosamine and chondroitin only, not full joint …
Studies, doses and limits
What the trials found
GAIT (24 weeks, 1,583 people): neither supplement alone nor the pair beat placebo for a 20% pain drop overall (pair +6.5 points, P = 0.09); in a moderate-to-severe pain subgroup the pair did better (79.2% vs 54.3%), an exploratory finding. MOVES (6 months, 606 people with severe pain): the pair matched celecoxib, with no placebo group. GAIT two-year follow-up (662 people): no treatment gave a clinically important difference. A 2018 review of 69 trials found glucosamine and chondroitin each improved pain by amounts of unclear importance. NCCIH says guidelines disagree: the 2019 US rheumatology and arthritis guideline strongly recommends against them for knee osteoarthritis, while a 2021 orthopaedic surgeons' guideline lists glucosamine as possibly helpful in mild-to-moderate disease, with cautions.
Results
Mixed. The best placebo-controlled trial was negative overall. One trial matched a drug but had no placebo group.
Effect sizes as reported
GAIT: pair +6.5 percentage points vs placebo (P = 0.09). MOVES: WOMAC pain -185.7 vs -186.8 with celecoxib. GAIT 2 years: odds of pain response 0.83 for the pair.
Why this rating
Mixed because the large placebo-controlled trial and its 2-year follow-up were negative overall, while a smaller trial matched celecoxib without a placebo group and a subgroup looked better.
Form and dose studied
These trials tested glucosamine and chondroitin only, not full joint blends. Amounts used appear in the studies table.
Who was studied
Adults with knee osteoarthritis (mean age 59 in GAIT).
Limits
Placebo effects were large (60% responded in GAIT). One trial lacked a placebo group. Results are for specific products and salts.
Why researchers looked
Knee osteoarthritis is the most common reason people buy joint blends, and glucosamine plus chondroitin is the core of most of them.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established. NCCIH describes glucosamine as a building block of cartilage molecules and chondroitin as a part of cartilage that resists squeezing, but it says it is still uncertain whether the supplements help symptoms.
A proposed mechanism does not show that the effect happens in people.
Side effects were mild and similar to placebo in GAIT and low in MOVES. See the Safety tab for warfarin and blood sugar.
Multi-ingredient joint blends tested as one product
Very low certaintyA few small trials tested a whole blend as one product. A 147-person trial found glucosamine and chondroitin with MSM beat placebo on pain at 12 weeks, while glucosamine and chondroitin alone did not. A 32-person pilot and a 70-person comparison also look positive. Each tested a different mix, so none shows that a blend on a shelf works.
4 studiesMixed products. No trial tested a mix of all five usual ingredients.
Studies, doses and limits
What the trials found
Lubis 2017 (147 people, 12 weeks, mild disease): glucosamine and chondroitin with MSM improved pain and WOMAC scores more than glucosamine and chondroitin alone or placebo (WOMAC p = 0.03, pain p = 0.004 at week 12). Nakasone 2011 (32 people, 16 weeks, pilot): a glucosamine-based mix with chondroitin, MSM, guava leaf extract and vitamin D gave a bigger improvement in pain than placebo; the authors call it not conclusive. Mazurov 2023 (70 people, 6 months, Russian trial): a capsule of undenatured type II collagen, boswellic acids, MSM, vitamins C and D3 matched glucosamine-chondroitin on pain, with no placebo group. A 2024 review of 30 trials listed glucosamine with chondroitin and MSM as reducing pain (low-quality evidence) but with effect sizes much larger than the largest trials.
Results
Positive signals from small trials of different mixes. No trial tested the blend most people buy.
Effect sizes as reported
Lubis: week-12 differences WOMAC p = 0.03, VAS p = 0.004. 2024 review: glucosamine + chondroitin + MSM SMD -2.25 (95% CI -3.84 to -0.67), low quality.
Why this rating
Very low because trials are small, each tested a different mix, one had no placebo group, and the abstracts give no funding details. The pooled effect sizes are unusually large and need caution.
Form and dose studied
Mixed products. No trial tested a mix of all five usual ingredients.
Who was studied
Adults with knee osteoarthritis (mild in the Lubis trial).
Limits
Small trials; different recipes; short follow-up; one open comparison without a placebo; no cross-checking by independent teams found.
Why researchers looked
Blends add extra ingredients in the hope of a bigger effect than glucosamine and chondroitin alone.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established. The mix of ingredients differs by trial, so no one pathway can be named.
A proposed mechanism does not show that the effect happens in people.
No clinically significant side effects were reported in the abstracts read.
Joint structure (cartilage and joint space)
Low certaintyResearchers also asked whether these supplements protect the joint itself. Results disagree. A pooled review found a small gain for chondroitin of unclear importance. Two-year trials of glucosamine and chondroitin gave conflicting results on joint space.
3 studiesGlucosamine and chondroitin trials; one blend capsule in the MRI tria…
Studies, doses and limits
What the trials found
A 2018 review of 69 trials found chondroitin gave a statistically significant but not clinically important structural improvement (effect size -0.30). NCCIH says two large 2-year trials conflicted: an Australian trial (605 people) found less joint space narrowing with the glucosamine-chondroitin pair, and the US GAIT structural study (572 people) found no difference from placebo. Two chondroitin-alone trials (622 and 300 people) found better joint space, which conflicts with the Australian and US trials. In the 70-person Mazurov trial, MRI showed cartilage ultrastructure improved in both groups and joint-lining swelling area fell more with a blend than with glucosamine-chondroitin.
Results
Conflicting. Not shown for blends in any placebo-controlled structure trial read.
Effect sizes as reported
Chondroitin effect size -0.30 (95% CI -0.42 to -0.17), judged not clinically important.
Why this rating
Low because trials disagree and the one blend result had no placebo group.
Form and dose studied
Glucosamine and chondroitin trials; one blend capsule in the MRI trial.
Who was studied
Adults with knee osteoarthritis.
Limits
Joint space on X-ray changes slowly and does not always match pain. Trials use different products.
Why researchers looked
Because glucosamine and chondroitin are parts of cartilage, people hoped they might slow cartilage loss.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
No joint-structure safety problems reported in the sources read.
Turmeric or curcumin (one usual ingredient)
Low certaintyTurmeric extracts are the best-studied add-on in joint blends. A review of 16 short trials found less knee pain than placebo, but trials differed a great deal. This is about turmeric alone, not about a blend.
3 studiesMany different turmeric extracts, some made to absorb better. Amounts…
Studies, doses and limits
What the trials found
Wang 2021 reviewed 16 trials (1,810 people, up to 16 weeks). Against placebo, turmeric extracts reduced knee pain (SMD -0.82) and improved function (SMD -0.75); against NSAIDs the effects were similar. People with a higher body mass index improved less. Imaging and blood markers did not differ. The 2018 review put Curcuma longa extract and curcumin among the supplements with large short-term pain effects, with very low quality evidence. NCCIH says we do not know enough to say definitely that turmeric or curcumin is beneficial for any health purpose; the early osteoarthritis evidence is positive but needs higher-quality studies.
Results
Short-term pain relief signal, not shown for long-term use or for blends.
Effect sizes as reported
Pain SMD -0.82 (95% CI -1.17 to -0.47, I2 86%); function SMD -0.75 (95% CI -1.18 to -0.33, I2 90%).
Why this rating
Low because differences between trials are very high, follow-up was up to 16 weeks and bias risk is moderate.
Form and dose studied
Many different turmeric extracts, some made to absorb better. Amounts are in the studies table.
Who was studied
Adults with knee osteoarthritis.
Limits
Product content varies (NCCIH). Liver injury has been reported with high-bioavailability products (see Safety).
Why researchers looked
Turmeric has a long history in traditional medicine for arthritis and is added to many joint blends.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established in people.
A proposed mechanism does not show that the effect happens in people.
Side effects were like placebo in the review, but see the liver warning on the Safety tab.
MSM (methylsulfonylmethane)
Low certaintyMSM has been tested in very few trials. Two small ones in knee osteoarthritis found less pain. Reviewers call the evidence positive but not definitive.
3 studiesMSM alone in these trials. Amounts are not given in the abstracts.
Studies, doses and limits
What the trials found
A 2008 review found two MSM trials (168 people) that both reported significant pain improvement, with concerns about methods, best amount and treatment length. The 2018 review put MSM among supplements with significant pain gains of unclear importance. A 2025 network analysis ranked MSM second for WOMAC pain among 21 supplements, with low evidence quality.
Results
Small positive signal from few trials.
Effect sizes as reported
Not pooled in the abstracts read.
Why this rating
Low because only two small MSM trials exist in the 2008 review and rankings in the 2025 review rest on low-quality evidence.
Form and dose studied
MSM alone in these trials. Amounts are not given in the abstracts.
Who was studied
Adults with knee osteoarthritis.
Limits
Few and small trials; long-term safety and best amount unknown according to the reviewers.
Why researchers looked
MSM is a sulfur compound often added to joint blends for joint comfort.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
No MSM safety problem was reported in the abstracts read.
Collagen in the mix (hydrolysed or undenatured type II)
Low certaintyBlends often add collagen. The 2018 review found collagen hydrolysate gave a large short-term pain effect and undenatured type II collagen was one of two supplements with a clinically important effect at medium term, but it rated the evidence very low overall. Collagen has its own page.
2 studiesHydrolysed collagen and undenatured type II collagen are different pr…
Studies, doses and limits
What the trials found
Liu 2018 (69 trials): collagen hydrolysate showed a large, clinically important short-term pain effect; undenatured type II collagen showed significant improvement and was clinically important at medium term. A 2025 network analysis (23 trials) ranked undenatured type II collagen third and collagen fourth for WOMAC pain, with low evidence quality. Different collagens are not the same thing, and these are results for the single ingredient.
Results
Positive signals for single collagen products in short trials.
Effect sizes as reported
No single effect size is quoted in the abstracts read.
Why this rating
Low because the review rated overall quality very low and ranking analyses are low quality.
Form and dose studied
Hydrolysed collagen and undenatured type II collagen are different products.
Who was studied
Adults with osteoarthritis.
Limits
Few trials per product; makers fund many collagen trials. See the collagen page for more.
Why researchers looked
Collagen is a main protein in cartilage, so it is a common add-on.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established in people.
A proposed mechanism does not show that the effect happens in people.
No safety signal in the abstracts read for osteoarthritis trials; fish collagen can trigger allergy in people with fish allergy (see the collagen page).
Other joints (hip, hand, jaw)
Not enough evidenceAlmost all the research is on the knee. For hip osteoarthritis, glucosamine did no better than placebo in the one high-quality trial. For hands, one 162-person trial of chondroitin found less pain. Evidence for the jaw joint is inconclusive.
1 studiesSingle ingredients, not blends.
Studies, doses and limits
What the trials found
NCCIH reports the 2017 orthopaedic surgeons' hip guideline did not support glucosamine sulfate for hip osteoarthritis, based on a 222-person 2-year trial with no benefit for pain, function or joint space. One 6-month trial in 162 people with hand osteoarthritis found chondroitin reduced pain and improved function more than placebo. A review of 8 studies (538 people) of glucosamine for jaw joint osteoarthritis could not reach definite conclusions.
Results
Little evidence; hip result negative.
Why this rating
Insufficient because each joint has one or very few trials, reported second-hand through NCCIH.
Form and dose studied
Single ingredients, not blends.
Who was studied
People with hip, hand or jaw osteoarthritis.
Limits
Reported through the NCCIH page; original papers were not read.
Why researchers looked
Joint blends are sold for all joints, but trials mostly studied knees.
Traditional use
Joint blends are sold for joint comfort and mobility. They usually mix glucosamine, chondroitin, MSM, turmeric or curcumin and collagen. Glucosamine and chondroitin are parts of cartilage, and NCCIH says chondroitin, with or without glucosamine, was the supplement most used by US adults aged 35 and over who had osteoarthritis (2017 survey).
Proposed mechanism Not established
Not established.
A proposed mechanism does not show that the effect happens in people.
See the Safety tab.
Connections to the rest of health
How Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric) connects to the rest of our health knowledge graph. Every link says what kind of connection it is. A safety link (for example to the liver) is a warning, not a benefit. A study that merely mentions a topic never creates a benefit link.
Explore every connection: goals, body systems, organs, symptoms, genes
A. Wellness goals
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Joint Support | Mixed findings | Glucosamine plus chondroitin pairs and knee osteoarthritis pain: The nearest thing to a tested joint blend is the glucosamine and chondroitin pair. The big US trial (GAIT, 1,583 people) found no clear pain benefit overall. A European trial found the pair did about as well as celecoxib, but it had no placebo group. Two years on, GAIT found no clinically important difference. Multi-ingredient joint blends tested as one product: A few small trials tested a whole blend as one product. A 147-person trial found glucosamine and chondroitin with MSM beat placebo on pain at 12 weeks, while glucosamine and chondroitin alone did not. A 32-person pilot and a 70-person comparison also look positive. Each tested a different mix, so none shows that a blend on a shelf works. | 4 18 8 10 15 12 14 13 19 20 16 2 3 | |
| Mobility Support | Mixed findings | Glucosamine plus chondroitin pairs and knee osteoarthritis pain: The nearest thing to a tested joint blend is the glucosamine and chondroitin pair. The big US trial (GAIT, 1,583 people) found no clear pain benefit overall. A European trial found the pair did about as well as celecoxib, but it had no placebo group. Two years on, GAIT found no clinically important difference. Multi-ingredient joint blends tested as one product: A few small trials tested a whole blend as one product. A 147-person trial found glucosamine and chondroitin with MSM beat placebo on pain at 12 weeks, while glucosamine and chondroitin alone did not. A 32-person pilot and a 70-person comparison also look positive. Each tested a different mix, so none shows that a blend on a shelf works. | 4 18 8 10 15 12 14 13 19 20 16 2 3 |
B. Body systems
E. Health conditions
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Knee osteoarthritis | Mixed findings | The large placebo-controlled trial was negative overall; smaller trials of blends are positive but different from each other. Glucosamine-chondroitin pairs were negative overall in the largest placebo-controlled trial; smaller trials of other mixes were positive. Preparation or compound: Glucosamine and chondroitin pairs and blends |
4 12 | |
| Drug- or supplement-induced liver injury | Adverse effect or risk | Documented risk | Acute hepatitis cases, which improved after stopping. Preparation or compound: High-absorption turmeric or curcumin |
11 17 |
I. Biomarkers
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Knee pain score (WOMAC pain) | Biological association | Mixed findings | Measured in trials: no clear change in the big placebo trial; similar to celecoxib in a trial with no placebo group. A lab change is not the same as a health benefit. | 4 8 12 |
| Pain on a 0 to 10 style line (VAS) | Biological association | Very low certainty | Measured in trials: lower pain in small trials of blends. A lab change is not the same as a health benefit. | 12 14 |
| Joint space width on X-ray | Biological association | Low certainty | Measured in trials: conflicting. A lab change is not the same as a health benefit. | 10 |
| MRI cartilage and joint-lining swelling | Biological association | Very low certainty | Measured in trials: improved in a small trial; no placebo group. A lab change is not the same as a health benefit. | 13 |
| Blood markers of cartilage breakdown (C2C) and joint lining (hyaluronan) | Biological association | Very low certainty | Measured in trials: lower, not statistically significant. A lab change is not the same as a health benefit. | 14 |
K. Biological pathways
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Collagen | Preliminary mechanism | Human | Often added to joint blends; has its own page. | 10 |
L. Active compounds
| Connected to | Kind of connection | Evidence status | Context | Studies |
|---|---|---|---|---|
| Glucosamine | Biological association | Human | NCCIH: a building block for molecules that form part of cartilage structure. | 15 4 |
| Chondroitin sulfate | Biological association | Human | NCCIH: a component of cartilage that helps it resist compression. | 15 4 |
| MSM (methylsulfonylmethane) | Biological association | Human | Studied in two small knee osteoarthritis trials. | 2 |
| Curcuminoids (curcumin) | Biological association | Human | The compounds usually credited for turmeric's effects. Some products add piperine from black pepper to help absorption. | 16 20 |
| Collagen (hydrolysed or undenatured type II) | Biological association | Human | Studied as hydrolysed collagen and as undenatured type II collagen in osteoarthritis trials. | 10 |
| Common add-ons seen in the blend trials | Biological association | Human | Each was tested only as part of one specific mix. | 13 14 19 |
Each connection is stored with the ingredient, the connected record, the kind of connection, the evidence status, the supporting studies, the preparation or compound involved, and a review date (last reviewed October 26, 2026).
Evidence at a glance: what the research found for 7 outcomes
Each outcome below is one thing researchers measured. Certainty is how far the evidence can be trusted, not how well it works. The full studies are on the next tab.
The evidence
The research centre for Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric). Every record here was checked against PubMed or the publisher's page; we never list a study we have not verified.
Evidence by outcome
Bars show how many studies we found for each outcome, not how well it works. People are added up across trials only (reviews are not added, to avoid double counting).
How we rate evidence
High certainty
Several well-run trials or reviews agree; further research is unlikely to change the picture much.
Moderate certainty
Good trials point the same way, but some doubt remains.
Low certainty
Small, short or inconsistent trials. The finding could change with better research.
Very low certainty
Very little or very weak human data. Treat as a possibility only.
Mixed findings
Trials or reviews disagree with each other.
Not enough evidence
Not enough human research to say either way.
Evidence against
Good research found no benefit, or found harm.
We take the reviewers' own risk-of-bias and GRADE statements where they exist, and otherwise judge from study size, design, consistency, directness and whether a product matches what is sold. Many publications do not make evidence high. Method note: We started from our existing joint-formula summary, then re-read PubMed abstracts for every review, trial, case report and lab study cited, and read the NCCIH glucosamine and chondroitin and turmeric pages in full. The EFSA statement was read as a PubMed abstract only. Only abstracts were read for journal articles.
Study library: every study we checked 22
| Study | Design | People | Product, dose, length | Result |
|---|---|---|---|---|
| Asthana 2019 Development and validation of a novel high performance liquid chromatography-coupled with Corona charged aerosol detector method for quantification of glucosamine in dietary supplements PLoS One · PMID 31059544 · DOI |
Laboratory analysis laboratory |
12 12 glucosamine dietary supplements bought in Australia (6) and India (6) |
Glucosamine dietary supplements Retail products · vs Label claim |
Australian products held 98.7 to 101.7% of the labelled glucosamine; Indian products held 85.9 to 101.8%. Only half of the Indian products were within 10% of the label. Australia 98.7-101.7% of label; India 85.9-101.8% of label (Not given in the abstract) Methods, limits and fundingOutcomes: Glucosamine measured against the amount on the label Limitations: Twelve products, glucosamine only, mainly a method paper. Does not cover chondroitin, MSM or turmeric amounts, or blends. Funding and conflicts: No funding statement in the abstract read. Read: abstract |
| Brien 2008 Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis Osteoarthritis Cartilage · PMID 18417375 · DOI |
Systematic review |
168 Six studies in knee osteoarthritis; two MSM trials with 168 people (52 on MSM) |
MSM (methylsulfonylmethane) and DMSO Oral Varied by trial Varied · vs Placebo or comparator |
Both MSM trials reported significant pain improvement versus comparators. The authors say the more rigorous MSM trials give positive but not definitive evidence in mild to moderate knee osteoarthritis, and that best amount, treatment length and long-term safety are unknown. Both MSM trials reported significant pain improvement (Not given in the abstract) Methods, limits and fundingOutcomes: Pain outcomes Limitations: Only two small MSM trials; concerns about methods, amount and treatment period. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Chen 2025 Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis J Integr Med · PMID 40425393 · DOI |
Systematic review network meta analysis |
2455 23 placebo-controlled trials of 21 dietary supplements, 2,455 people with osteoarthritis |
21 dietary supplements, including MSM, undenatured type II collagen and collagen Oral Varied by trial Varied · vs Placebo |
Passion fruit peel extract ranked first for WOMAC pain and function. For pain, MSM ranked second (89%), undenatured type II collagen third (87%) and collagen fourth (84%). The authors rate the evidence quality as low. WOMAC pain ranking (SUCRA): MSM 89%, undenatured type II collagen 87%, collagen 84% (Passion fruit peel pain MD -9.2 (-16.0 to -2.3)) Methods, limits and fundingOutcomes: WOMAC pain and function scores Limitations: Low evidence quality (GRADE). Rankings are not the same as proof of benefit. Glucosamine, chondroitin and turmeric are not named among the top ranks in the part of the abstract read. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Clegg 2006 Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med · PMID 16495392 · DOI |
Randomised controlled trial |
1583 1,583 people with painful knee osteoarthritis (mean age 59; 64% women); 1,229 mild pain, 354 moderate-to-severe pain |
Glucosamine, chondroitin sulfate, or both Oral 1,500 mg glucosamine and/or 1,200 mg chondroitin sulfate a day (studied in the trial) 24 weeks · vs Placebo and celecoxib (200 mg a day); rescue acetaminophen allowed |
Overall, neither supplement alone nor both together beat placebo for a 20% pain drop (placebo 60.1% responded; combination +6.5 points, P = 0.09). In the moderate-to-severe pain group the combination did better than placebo (79.2% vs 54.3%, P = 0.002), but the authors call this exploratory. Side effects were mild, infrequent and similar across groups. Combination vs placebo: +6.5 percentage points (P = 0.09); moderate-to-severe pain subgroup 79.2% vs 54.3% (P = 0.002) (Not given in the abstract) Methods, limits and fundingOutcomes: A 20% drop in knee pain from the start Limitations: The subgroup result was an exploratory look. Two separate supplements, not one blended product. Trial is 20 years old. Funding and conflicts: Public research funding (NIH) is listed in the PubMed record. Read: abstract |
| Dostrovsky 2011 The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature Osteoarthritis Cartilage · PMID 21251987 · DOI |
Systematic review |
Eleven human studies (six randomised trials, five prospective studies) | Glucosamine (all preparations together) Oral Varied Varied · vs Placebo or no control in some |
Four of the eleven studies found lower insulin sensitivity or higher fasting glucose with glucosamine, three of them with oral glucosamine. Studies that included people with impaired glucose tolerance or insulin resistance were more likely to find an effect. The authors call the evidence mixed and ask for more studies in people at high risk. 4 of 11 studies found a change (Not given in the abstract) Methods, limits and fundingOutcomes: Insulin sensitivity and fasting glucose Limitations: Mixed designs; the review does not separate preparations. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| EFSA Panel on Dietetic Products 2011 Statement on the safety of glucosamine for patients receiving coumarin anticoagulants EFSA J · PMID 42015979 · DOI |
Regulator scientific statement human (case reports) |
More than 40 case reports collected by drug-monitoring agencies | Glucosamine with coumarin anticoagulants (such as warfarin) Oral |
The European panel found more than 40 case reports of higher INR after starting glucosamine in people on coumarin blood thinners, mostly without symptoms but with bleeding in some and one persistent vegetative state. In most cases INR fell after glucosamine was stopped. It concluded there is evidence of a risk of interaction in some people that could lead to bleeding, that the level of risk cannot be worked out, and that the mechanism is unknown. More than 40 case reports; risk level cannot be worked out (Not given in the abstract) Methods, limits and fundingOutcomes: INR rise and bleeding Limitations: Case reports only; no dose-response could be drawn. Funding and conflicts: Independent European food-safety panel statement; no industry funding noted in the abstract. Read: abstract |
| Forsyth 2019 Turmeric means "yellow" in Bengali: Lead chromate pigments added to turmeric threaten public health across Bangladesh Environ Res · PMID 31550596 · DOI |
Laboratory and field survey laboratory |
524 152 interviews and 524 samples of turmeric, pigments, dust and soil from Bangladesh markets and mills |
Turmeric spice powder (not supplement capsules) Powder |
Lead chromate yellow pigment was added to turmeric in 7 of the 9 main turmeric-growing districts. The highest lead level in turmeric powder was 1,152 micrograms per gram. Traders said the practice began over 30 years ago and is driven by demand for bright yellow curry. This is a survey of the spice trade in Bangladesh, not of supplement capsules. Maximum lead in turmeric powder 1,152 ug/g (Not given in the abstract) Methods, limits and fundingOutcomes: Lead and chromium in turmeric and pigments Limitations: Spice markets in one country; it says nothing direct about turmeric extracts in joint capsules. Funding and conflicts: No funding statement in the abstract read. Read: abstract |
| Hochberg 2016 Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib Ann Rheum Dis · PMID 25589511 · DOI |
Randomised controlled trial |
606 606 people with knee osteoarthritis (grades 2-3) and moderate-to-severe pain, in France, Germany, Poland and Spain |
Chondroitin sulfate plus glucosamine hydrochloride (one combined product) Oral 400 mg chondroitin sulfate plus 500 mg glucosamine hydrochloride three times a day (studied in the trial) 6 months · vs Celecoxib 200 mg a day (no placebo group) |
WOMAC pain fell about 50% in both groups (-185.7 with the supplement pair vs -186.8 with celecoxib), meeting the non-inferiority margin. Joint swelling fell more than 50% in both. Side effects were low and similar. Difference between groups -1.11 on the WOMAC pain scale (p = 0.92 for non-inferiority) (-1.11 (-22.0 to 19.8)) Methods, limits and fundingOutcomes: WOMAC pain change; joint swelling and effusion; function; side effects Limitations: No placebo group, so it cannot show the supplements beat placebo. People with severe pain; the pain fell in both groups. Funding and conflicts: The PubMed record lists non-US-government research support; the abstract does not name a sponsor. Read: abstract |
| Knudsen 2008 Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database Pharmacotherapy · PMID 18363538 · DOI |
Case report and database review human (case report) |
1 A 71-year-old man on warfarin for atrial fibrillation, plus 20 US FDA MedWatch reports and 21 WHO reports |
Glucosamine or glucosamine-chondroitin with warfarin Oral Case: supplement amount was raised, then lowered, then stopped Weeks |
After the man raised his glucosamine and chondroitin, his INR went from 2.3 to 3.9, then 4.7. After he stopped the supplement and his warfarin was adjusted, it fell to 2.6. Twenty FDA reports described changed clotting or more bruising or bleeding, and one involved a brain bleed with lasting severe harm. In the WHO database 21 reports of higher INR were found, 17 of which settled when glucosamine stopped. The authors say the interaction needs more information to define. Case INR 2.3 to 3.9 to 4.7; FDA 20 reports; WHO 21 reports, 17 resolved on stopping (Not given in the abstract) Methods, limits and fundingOutcomes: INR (a clotting-time test) and bleeding Limitations: Case report and spontaneous reports cannot prove cause or give a rate. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Liu 2018 Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis Br J Sports Med · PMID 29018060 · DOI |
Systematic review meta analysis |
69 randomised trials of 20 supplements versus placebo in hand, hip or knee osteoarthritis | 20 oral supplements, including glucosamine, chondroitin, MSM, curcumin, Curcuma longa extract, collagen hydrolysate and undenatured type II collagen Oral Varied by trial Short, medium and long term · vs Placebo |
Seven supplements (including collagen hydrolysate, Curcuma longa extract and curcumin) showed large short-term pain effects. Six (including glucosamine, chondroitin, MSM and undenatured type II collagen) improved pain by amounts of unclear importance. Only green-lipped mussel extract and undenatured type II collagen had clinically important effects at medium term. None did at long term. Chondroitin gave a small structural improvement of unclear importance. Safety did not differ from placebo except for diacerein. Evidence quality ran from very low to high; overall it was very low. Chondroitin on joint structure: effect size -0.30 (-0.42 to -0.17 (chondroitin, joint structure)) Methods, limits and fundingOutcomes: Pain, physical function, joint structure, safety Limitations: Overall quality of evidence very low. Some supplements had few trials and few people. Single ingredients, not blends. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Lombardi 2021 Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports Br J Clin Pharmacol · PMID 32656820 · DOI |
Case series systematic review human (case reports) |
30 7 Tuscan cases of acute hepatitis plus 23 cases from a systematic review of published case reports |
Curcuma longa (turmeric) dietary supplements Oral supplements Varied |
In all seven Tuscan cases the liver injury was linked to turmeric products with high bioavailability and high amounts of curcuminoids. Most improved after stopping. Of the 23 published cases, most people also took another medicine and 16 got better after stopping. The authors conclude turmeric is associated with liver injury. 7 Tuscan cases; 23 published cases, 16 with positive dechallenge (Not given in the abstract) Methods, limits and fundingOutcomes: Liver injury; causality scores (RUCAM, WHO-UMC); recovery after stopping Limitations: Case reports cannot give a rate. Many patients took other medicines. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Lubis 2017 Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial Acta Med Indones · PMID 28790224 |
Randomised controlled trial |
147 147 people with mild knee osteoarthritis (Kellgren-Lawrence grade I-II) in three groups (49, 50 and 48) |
Glucosamine plus chondroitin sulfate, with or without MSM (methylsulfonylmethane) Oral capsules 1,500 mg glucosamine and 1,200 mg chondroitin sulfate, with or without 500 mg MSM, once a day (studied in the trial) 12 weeks · vs Placebo |
At week 12 the three groups differed on WOMAC (p = 0.03) and on pain VAS (p = 0.004). The group with MSM added improved more than the glucosamine-chondroitin group and placebo. Glucosamine-chondroitin alone did not give a clear improvement. Between-group differences at week 12: WOMAC p = 0.03; VAS p = 0.004 (Not given in the abstract) Methods, limits and fundingOutcomes: Pain (VAS) and WOMAC scores at weeks 4, 8 and 12 Limitations: One 3-month trial in mild disease; the abstract gives no effect sizes, funding or side effect data. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Mazurov 2023 Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint Ter Arkh · PMID 38785054 · DOI |
Randomised controlled trial |
70 70 people with stage I-III primary knee osteoarthritis (35 per group); Russian-language article, English abstract read |
One capsule combining undenatured type II collagen, boswellic acids, MSM, vitamin C and vitamin D3 Oral capsule 1 capsule a day versus the standard glucosamine-chondroitin regimen (studied in the trial) 6 months · vs Glucosamine hydrochloride plus chondroitin sulfate (no placebo) |
Pain and WOMAC improved in both groups with no difference between them. The blend group had a larger fall in stiffness and, on MRI, a larger fall in the area of joint-lining swelling (2.95-fold vs 1.37-fold). Cartilage ultrastructure improved in both groups. No clinically significant side effects were seen. The authors call the blend not inferior to glucosamine-chondroitin. Pain and WOMAC: no difference between groups; swelling area down 2.95-fold (blend) vs 1.37-fold (glucosamine-chondroitin) (Not given in the abstract) Methods, limits and fundingOutcomes: WOMAC, pain, Lequesne index, stiffness, SF-36, MRI of cartilage and joint lining Limitations: Small, no placebo group, one named product, and the abstract does not say who paid. Not a test against placebo. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Nakasone 2011 Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study Exp Ther Med · PMID 22977594 · DOI |
Randomised controlled trial |
32 32 people with symptomatic knee osteoarthritis |
One combined product: glucosamine with chondroitin sulfate, MSM, guava leaf extract and vitamin D Oral Glucosamine 1,200 mg a day plus the other ingredients (studied in the trial) 16 weeks · vs Placebo |
The pain part of the JKOM improved at all four checks in the supplement group but not in the placebo group. Total symptoms differed between groups at week 8 only (P < 0.05). Blood markers fell 10% (C2C) and 25% (hyaluronan) in the supplement group, not statistically significant. The authors call the results not conclusive. Total symptoms and 'general activities' differed between groups at week 8 (P < 0.05); C2C -10%, hyaluronan -25% (not significant) (Not given in the abstract) Methods, limits and fundingOutcomes: Japanese Knee Osteoarthritis Measure (JKOM), diary pain scale, blood markers of cartilage breakdown (C2C) and joint lining (hyaluronan) Limitations: Pilot trial of 32 people. Mixed product, so no single ingredient can be credited. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| National Center for Complementary and Integrative Health (US) 2023 NCCIH: Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know (page last updated October 2023) NCCIH health information page · Source |
Regulator fact page |
Not applicable | Glucosamine and chondroitin Oral |
Read in full on 2026-10-26. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Evidence summary, guidelines, safety Limitations: A summary of other studies, not a new study. Funding and conflicts: US government health agency. Read: full page |
| National Center for Complementary and Integrative Health (US) 2025 NCCIH: Turmeric: Usefulness and Safety (page last updated April 2025) NCCIH health information page · Source |
Regulator fact page |
Not applicable | Turmeric and curcumin Oral |
Read in full on 2026-10-26. Not applicable (Not applicable) Methods, limits and fundingOutcomes: Evidence summary, guidelines, safety Limitations: A summary of other studies, not a new study. Funding and conflicts: US government health agency. Read: full page |
| Papke DJ Jr 2025 Turmeric supplement-associated hepatitis: a clinicopathological series of 11 cases highlighting pan-lobular and zone 3 injury Histopathology · PMID 39381846 · DOI |
Case series human (case series) |
11 11 patients (10 women, median age 58) with liver injury attributed to turmeric supplements |
Over-the-counter turmeric supplements Oral supplements Varied |
Six people had no symptoms, only abnormal liver tests; five had tiredness or jaundice. Biopsies mostly showed acute hepatitis. All stopped the supplement, four also received steroids, and liver tests returned to normal in all. Causality was probable in eight and possible in three. 11 cases; liver tests normalised in all after stopping (Not given in the abstract) Methods, limits and fundingOutcomes: Liver tests, biopsy findings, causality score (RUCAM) Limitations: Hospital pathology series, not a rate. Brands and amounts not stated in the abstract. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Sawitzke 2010 Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT Ann Rheum Dis · PMID 20525840 · DOI |
Randomised controlled trial |
662 662 people with knee osteoarthritis (Kellgren/Lawrence grade 2 or 3) from nine US sites who stayed on their GAIT treatment |
Glucosamine, chondroitin sulfate, or both Oral Glucosamine 500 mg and/or chondroitin 400 mg three times a day (studied in the trial) 24 months · vs Placebo and celecoxib (200 mg a day) |
Compared with placebo, the odds of a 20% pain drop were 1.16 for glucosamine, 0.83 for the combination and 0.69 for chondroitin alone, none statistically significant. No treatment gave a clinically important difference in pain or function. Serious side effects were rare and similar across groups. Odds of 20% WOMAC pain drop vs placebo: glucosamine 1.16, combination 0.83, chondroitin 0.69, celecoxib 1.21 (none significant) (Not given in the abstract) Methods, limits and fundingOutcomes: A 20% drop in WOMAC pain; OMERACT-OARSI response; pain and function change Limitations: A subgroup of the original trial, not a new trial. Separate supplements, not a blended product. Funding and conflicts: Public research funding (NIH) is listed in the PubMed record. Read: abstract |
| Sumsuzzman 2024 Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis J Clin Med · PMID 39685902 · DOI |
Systematic review network meta analysis |
5265 30 randomised trials, 5,265 people with knee osteoarthritis |
Glucosamine-based combinations (with omega-3, ibuprofen, chondroitin sulfate and MSM, and others) Oral Varied by trial Varied · vs Placebo and single treatments |
Glucosamine with omega-3 (SMD -2.59, moderate quality), glucosamine with ibuprofen (SMD -2.27, moderate quality) and glucosamine with chondroitin sulfate and MSM (SMD -2.25, low quality) cut pain more than placebo. No other combination reached the review's threshold for a meaningful change (0.40). Glucosamine + chondroitin + MSM vs placebo: SMD -2.25 (-3.84 to -0.67 (glucosamine + chondroitin + MSM)) Methods, limits and fundingOutcomes: Overall knee pain (standardised mean difference) Limitations: The effect sizes are far larger than those in the largest single trials (for example GAIT), so they should be read with care. The glucosamine-chondroitin-MSM result is low quality. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Wang 2021 Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials Curr Rheumatol Rep · PMID 33511486 · DOI |
Systematic review meta analysis |
1810 16 randomised trials (up to 16 weeks) in 1,810 adults with knee osteoarthritis; 11 versus placebo, 5 versus pain-relief drugs (NSAIDs) |
Turmeric extracts (all types) Oral Varied by trial Up to 16 weeks · vs Placebo or NSAIDs |
Against placebo, turmeric extracts reduced knee pain and improved function, but trials differed a lot from each other. Against NSAIDs the effects were similar. People with a higher body mass index improved less. No clear differences in blood markers or imaging. Side effects were similar to placebo and 12% fewer than with NSAIDs. The authors note moderate risk of bias and some uncertainty. Pain SMD -0.82; function SMD -0.75 versus placebo (Pain -1.17 to -0.47 (I2 = 86%); function -1.18 to -0.33 (I2 = 90%)) Methods, limits and fundingOutcomes: Knee pain and physical function; blood markers; imaging; side effects Limitations: Very high differences between trials; short follow-up; moderate risk of bias; many different turmeric products pooled. Funding and conflicts: No funding or conflict statement in the abstract read. Read: abstract |
| Yokotani 2014 Glucosamine and chondroitin sulfate do not enhance anticoagulation activity of warfarin in mice in vivo Shokuhin Eiseigaku Zasshi · PMID 25212820 · DOI |
Animal study mouse |
Mice fed glucosamine or chondroitin sulfate in the diet for 2 weeks, then given warfarin | Glucosamine or chondroitin sulfate In diet Mouse amounts only (about 440 to 1,550 mg per kg a day) 2 weeks · vs Diet without the supplements |
The supplements did not switch liver warfarin-processing enzymes up or down. The higher glucosamine amount slightly shortened clotting time in warfarin-treated mice. The authors conclude they do not boost warfarin through those liver enzymes. No effect on liver enzymes; clotting time slightly shorter at the high glucosamine amount (Not given in the abstract) Methods, limits and fundingOutcomes: Clotting times and liver enzymes that break down warfarin Limitations: Mouse study. It tested one possible mechanism only and does not rule out a human interaction. Funding and conflicts: No funding or conflict statement in the abstract read (Japanese-language article with an English abstract). Read: abstract |
| s-site-summary Existing AlternativeMed joint-formula summary (read 2026-10-26) |
Internal summary n/a |
Methods, limits and fundingRead: summary-only |
What we do not know yet
- No trial tested a blend of glucosamine, chondroitin, MSM, turmeric and collagen as one product.
- No independent repeat was found of the glucosamine, chondroitin and MSM trial.
- No survey of label accuracy, heavy metals or undeclared ingredients in full joint blends was found.
- Pregnancy, breastfeeding, children and kidney disease were not covered by the sources read, apart from the NCCIH statements.
- No official upper limit was read for glucosamine, chondroitin, MSM or curcumin.
- Shellfish allergy and glucosamine: no source was read.
How new research is added
New studies are found by a saved PubMed search and placed in a review queue before the page changes.
Lab markers
What changed in blood or saliva tests during trials. A changed number is not the same as feeling or being healthier, and we give no "normal ranges".
Other 5
Knee pain score (WOMAC pain)
No clear change in the big placebo trial; similar to celecoxib in a trial with no placebo group in trials
WOMAC is a questionnaire where people rate knee pain, stiffness and difficulty with daily tasks. Lower is better.
Mixed findingsResults and what it means
Why it was measured
To see whether a joint product eases everyday knee pain.
Statistical vs. clinical meaning
A questionnaire score, so placebo effects matter. The change is real to the person but it is not a measure of joint repair.
Safety implication
No safety signal in these trials.
| Study | Result | People | Product |
|---|---|---|---|
| 4 | No significant difference from placebo for a 20% pain drop overall | 1,583 people with knee osteoarthritis | Glucosamine, chondroitin or both for 24 weeks |
| 8 | WOMAC pain -185.7 vs -186.8 with celecoxib (non-inferior) | 606 people with severe knee pain | Chondroitin sulfate plus glucosamine hydrochloride for 6 months |
| 12 | Week-12 difference between groups p = 0.03 (WOMAC) | 147 people with mild knee osteoarthritis | Glucosamine and chondroitin with or without MSM for 12 weeks |
Pain on a 0 to 10 style line (VAS)
Lower pain in small trials of blends in trials
A visual analogue scale: people mark their pain on a line from none to worst.
Very low certaintyResults and what it means
Why it was measured
A simple daily measure of pain used in the blend trials.
Statistical vs. clinical meaning
Small trials of different mixes; no independent repeat.
Safety implication
No safety signal reported in the abstracts.
| Study | Result | People | Product |
|---|---|---|---|
| 12 | Week-12 difference between groups p = 0.004 | 147 people | Glucosamine and chondroitin with MSM vs without vs placebo |
| 14 | All three diary pain scores improved in the blend group only at nearly every check | 32 people | Glucosamine-based mix with chondroitin, MSM, guava leaf and vitamin D for 16 weeks |
Joint space width on X-ray
Conflicting in trials
The gap between the leg bones at the knee. Cartilage loss narrows it.
Low certaintyResults and what it means
Why it was measured
A slow measure of whether cartilage is being lost.
Statistical vs. clinical meaning
Changes are small and trials disagree.
Safety implication
No problem reported.
| Study | Result | People | Product |
|---|---|---|---|
| 10 | Chondroitin: effect size -0.30 (-0.42 to -0.17), not clinically important | Pooled osteoarthritis trials | Chondroitin |
MRI cartilage and joint-lining swelling
Improved in a small trial; no placebo group in trials
MRI measures of the cartilage's internal structure (T2 time) and the area of swollen joint lining.
Very low certaintyResults and what it means
Why it was measured
To look at the joint rather than only at pain.
Statistical vs. clinical meaning
One small trial without a placebo group.
Safety implication
No clinically significant side effects reported.
| Study | Result | People | Product |
|---|---|---|---|
| 13 | Joint-lining swelling area fell 2.95-fold with the blend and 1.37-fold with glucosamine-chondroitin; cartilage structure improved in both | 70 people with knee osteoarthritis | One capsule of undenatured type II collagen, boswellic acids, MSM, vitamins C and D3 vs glucosamine-chondroitin, 6 months |
Blood markers of cartilage breakdown (C2C) and joint lining (hyaluronan)
Lower, not statistically significant in trials
C2C is a fragment released when type II collagen in cartilage breaks down. Hyaluronan rises with joint-lining inflammation.
Very low certaintyResults and what it means
Why it was measured
To look for body-chemistry changes behind the pain scores.
Statistical vs. clinical meaning
32 people and not significant.
Safety implication
No problem reported.
| Study | Result | People | Product |
|---|---|---|---|
| 14 | C2C fell 10% and hyaluronan 25% at week 16 in the blend group; not statistically significant | 32 people with knee osteoarthritis | Glucosamine-based mix with chondroitin, MSM, guava leaf and vitamin D |
Safety
What studies and official sources say about side effects, medicines and who should check first. Each point shows what kind of evidence it comes from.
Main points to know 4
- Turmeric and curcumin supplements have been linked to liver injury. A European review found 7 Italian cases of acute hepatitis linked to turmeric supplements with high absorption and high curcuminoid content, and 23 more published cases. A US hospital series of 11 people found biopsy-proven liver injury; liver tests returned to normal after they stopped the supplement, and four also took steroids. NCCIH says highly absorbable curcumin products may harm the liver and to stop and talk to a health professional if you notice tiredness, nausea, poor appetite, dark urine or yellow skin or eyes. Many joint blends contain turmeric or curcumin. Case series, systematic review of case reports and regulator statement 11 17 16
- Glucosamine can raise INR in people taking warfarin. The European Food Safety Authority found more than 40 case reports of a higher INR (a clotting-time test) after starting glucosamine in people on coumarin blood thinners such as warfarin. Most had no symptoms, some bled, and in one case a brain bleed left lasting severe harm. In most cases INR came down when glucosamine stopped. The panel said the level of risk cannot be worked out and the cause is unknown. NCCIH also says glucosamine and chondroitin have been linked to more bleeding with warfarin. A mouse study found no effect on the liver enzymes that process warfarin. Ask a pharmacist before using any joint blend if you take a blood thinner. Regulator statement, case report and drug reaction database reports; mouse study 6 9 21 15
- Stacking: the same ingredient may be in several of your products. Joint blends often repeat ingredients found in other products, such as turmeric or curcumin, collagen, vitamin C, vitamin D, omega-3 and boswellia. Amounts add up across products. No study of stacking joint products was found; read every label and keep a list for your pharmacist. Practical note; no study found 22
- Glucosamine may affect blood sugar in some people. NCCIH says glucosamine may raise blood sugar in some people. A review of 11 human studies found mixed results: four found lower insulin sensitivity or higher fasting glucose, more often in people who already had impaired glucose tolerance or insulin resistance. People with diabetes or prediabetes should ask their care team. Systematic review (mixed) and regulator statement 5 15
Side effects 5
| Effect | How often | Severity and recovery | Evidence |
|---|---|---|---|
| Mild, infrequent side effects, similar to placebo, in the large glucosamine-chondroitin trials Rates of specific complaints are not given in the abstracts read. | Not different between groups in GAIT; low and similar to celecoxib in MOVES; serious events rare in the 2-year GAIT follow-up | Mild Not applicable | Randomised trials 4 8 18 |
| Stomach upset, nausea, reflux, diarrhoea or constipation with turmeric NCCIH says conventional oral turmeric is likely safe in recommended amounts for 2 to 3 months. | No rate given | Mild Expected to settle on stopping (not stated) | Regulator statement 16 |
| Liver injury with high-absorption turmeric or curcumin products Case reports cannot give a rate. | No rate; 30 reported cases in one review, 11 in one hospital series | Ranged from no symptoms to jaundice; some needed steroids Liver tests returned to normal after stopping in the 11-case series; 16 of 23 published cases improved after stopping | Case series and case reports 11 17 |
| Higher INR and bleeding risk with warfarin (glucosamine, with or without chondroitin) Cause and effect are not settled. | More than 40 case reports (EFSA); 20 FDA MedWatch and 21 WHO reports in one review | Usually no symptoms; bleeding in some; one report of lasting severe brain injury INR fell after stopping in most cases | Case reports and regulator statement 6 9 |
| Possible changes in blood sugar with glucosamine More likely in people with impaired glucose tolerance. | Four of 11 human studies found a change | Not stated Not stated | Systematic review 5 |
Liver
Turmeric and curcumin supplements, especially those made to be absorbed better, have been linked to acute liver injury. A 2021 review described 7 Italian cases, all with high-bioavailability, high-curcuminoid products, plus 23 published cases. A 2025 series of 11 people (10 women, median age 58) found acute hepatitis on biopsy in most; six had no symptoms and five had tiredness or jaundice. Liver tests returned to normal in all after stopping, and four got steroids. Causality was rated probable in eight and possible in three. NCCIH tells people with liver damage symptoms to stop and call a health provider. 11 17 16
How often. No rate in users was found; the cases come from reports and hospital archives.
Monitoring. No agency monitoring advice was found beyond NCCIH's advice to stop and talk to a provider if liver symptoms appear.
- p39381846.
- p32656820.
This is a safety connection. It is not evidence that Joint Formulas (Glucosamine, Chondroitin, MSM, Turmeric) supports liver health.
Medicines and supplements 5
| With | Why it matters | Importance | Evidence | What to do |
|---|---|---|---|---|
| Warfarin and other coumarin blood thinners prescription | Not known. A mouse study found no effect on the liver enzymes that process warfarin. | More than 40 case reports of higher INR, some with bleeding (EFSA 2011). NCCIH also links glucosamine and chondroitin to more bleeding with warfarin. | Regulator statement and case reports Low certainty 6 9 21 15 | Do not start a joint blend without asking a pharmacist or the clinic that manages your INR. |
| Diabetes medicines and blood sugar control prescription | Glucosamine may affect how the body handles glucose. | Mixed evidence from 11 human studies; more likely in people with impaired glucose tolerance. | Systematic review Low certainty 5 15 | Tell your care team if you have diabetes or prediabetes. |
| Other blood thinners and supplements that affect clotting supplement | No mechanism found for the blends themselves. | No study of joint blends with antiplatelet drugs, fish oil, ginkgo or similar supplements was found. | Absence of evidence Not enough evidence | Absence of a study is not proof of safety. Ask a pharmacist. |
| Other turmeric, curcumin, collagen, vitamin C or vitamin D products supplement | Amounts add up across products. | No study of stacking joint products was found. | Absence of evidence Not enough evidence 22 | Check every label; keep a list for your pharmacist. |
| Prescription medicines (general) prescription | No mechanism found for the blends as a type. | NCCIH advises talking with your provider before using any herbal product if you take any medicine, because some herbs and medicines interact in harmful ways. | Regulator statement Not enough evidence 16 | Bring the full label to your doctor or pharmacist. |
Who should check first 8
| Situation | Advice | Evidence |
|---|---|---|
| Taking warfarin or another coumarin blood thinner | Ask a pharmacist or your clinic before using any product that contains glucosamine. | Regulator statement and case reports 6 15 |
| Liver disease, or any signs of liver trouble | Tell a clinician before using a product with turmeric or curcumin. If you notice tiredness, nausea, poor appetite, dark urine or jaundice, stop and talk to a health provider. | Regulator statement and case series 16 17 |
| Diabetes, prediabetes or insulin resistance | Ask your care team before using a product with glucosamine. | Systematic review and regulator statement 5 15 |
| Shellfish allergy | Some glucosamine is made from shellfish shells. Whether this raises allergy risk is debated, and no source on this was read for this page. Check the label for the source and ask an allergist. | No source read |
| Fish allergy (some collagen is made from fish) | Check the collagen source on the label. See the collagen page for the fish-allergy reports. | See collagen page |
| Pregnancy and breastfeeding | NCCIH says turmeric supplements in pregnancy may be unsafe, and that little is known about glucosamine and chondroitin in pregnancy or breastfeeding. Ask your prenatal clinician before using any joint blend. | Regulator statement 16 15 |
| Children | No source on joint blends in children was read. Ask a paediatrician or pharmacist. | No source read |
| Kidney disease, or before surgery | No source on kidney disease or on stopping joint products before surgery was read. Tell your care team about every supplement. | No source read |
Overdose, product quality and regulators
Summary. No major safety problems were found in large trials of glucosamine and chondroitin, according to NCCIH. The main concerns are liver injury with turmeric products, blood-thinner interactions with glucosamine, and blood sugar effects.
Animal. One mouse study on warfarin was read; broader animal toxicity was not reviewed.
High dose or long term signals. The 2-year GAIT follow-up reported similar side effects across groups. The liver cases involved high-bioavailability, high-curcuminoid products.
Overdose response. Not found.
Genotoxicity. Not researched.
Joint blends are dietary supplements. In the US they are not approved by the FDA before sale, and makers are responsible for the safety and labelling of their products, NCCIH says. Studies of what is actually in the bottle are few. NCCIH notes that curcumin products vary in how much curcumin they contain and often include other plant substances such as piperine from black pepper.
Glucosamine content versus the label. In 12 products, Australian ones held 98.7 to 101.7% of the labelled glucosamine, Indian ones 85.9 to 101.8%. Only half of the Indian products were within 10% of the label. 1
Curcumin content and added plant substances. Oral curcumin products vary in the amount of curcumin they hold and often contain other plant substances, such as piperine from black pepper. 16
Lead in turmeric spice (not supplements). In Bangladesh, lead chromate yellow pigment was added to turmeric in 7 of 9 main growing districts, with up to 1,152 micrograms of lead per gram in powder. This is a spice-market survey. No lead survey of turmeric joint capsules was read. 7
Proprietary blends. A label that lists a blend total without each amount makes it hard to tell if a product holds the amounts that trials used. This page did not re-check the labelling rules against official text. 22
| Body | Action | Date |
|---|---|---|
| NCCIH (US National Center for Complementary and Integrative Health) (United States) | Says it is still uncertain whether glucosamine and chondroitin help knee osteoarthritis; no major safety problems in large studies, but glucosamine may raise blood sugar in some people, both are linked to more bleeding with warfarin, and little is known about pregnancy and breastfeeding. source | 2023-10 |
| NCCIH (US National Center for Complementary and Integrative Health) (United States) | Says not enough is known to say definitely if turmeric or curcumin is beneficial for any health purpose; highly absorbable curcumin products may harm the liver; turmeric supplements in pregnancy may be unsafe. source | 2025-04 |
| European Food Safety Authority (EFSA) NDA Panel (European Union) | Concluded there is evidence of a risk of interaction between glucosamine and coumarin anticoagulants in some individuals that could lead to bleeding; the level of risk cannot be worked out. source | 2011-12-08 |
| American College of Rheumatology and Arthritis Foundation (as reported by NCCIH) (United States) | NCCIH reports the 2019 guideline strongly recommended against glucosamine and chondroitin, alone or together, for knee osteoarthritis, because the best data show no important benefit. A 2021 orthopaedic surgeons' guideline lists glucosamine among supplements that may help mild-to-moderate knee osteoarthritis, with cautions. source | 2019 |
When to get medical help
- Yellow skin or eyes, dark urine, pale stools, severe tiredness, nausea or poor appetite while taking a turmeric or curcumin product: stop the product and contact a health provider.
- Unusual bruising, nosebleeds that will not stop, blood in urine or stool, black stools or a severe headache while on warfarin and a glucosamine product: seek urgent medical care.
- Swelling of the face, lips or tongue, hives, wheezing or trouble breathing after a joint product: call emergency services.
- A hot, red, very swollen joint, fever, or sudden severe joint pain: see a clinician promptly, because these are not routine arthritis symptoms.
Stop using the product and contact a clinician or emergency service. In the US, Poison Control is 1-800-222-1222.
General information only, not medical advice. Ask a clinician or pharmacist before use, especially with medicines, in pregnancy or with a health condition. See the Natural Remedy Safety guide.
Frequently asked questions
What is a joint formula?
A joint formula is a supplement that combines several ingredients, usually glucosamine, chondroitin, MSM, turmeric or curcumin and collagen, and is sold for joint comfort.
Do joint supplements work?
Is a blend better than one ingredient?
Does glucosamine and chondroitin protect cartilage?
Is turmeric in joint blends effective?
Can a joint supplement harm the liver?
Can I use a joint blend with warfarin?
Is glucosamine safe for people with diabetes?
Is the amount on the label what is in the bottle?
Are joint supplements safe in pregnancy?
Do they work for hips and hands?
Little research exists. The one high-quality hip trial found no benefit from glucosamine. One hand trial of chondroitin found less pain.
Is turmeric spice the same as a curcumin capsule?
Explore by health goal
Editorial transparency
- Written by
- AlternativeMed editorial team. Research compiled with AI assistance, then checked against the sources listed.
- Medical review
- None. This page has not been reviewed by a physician or pharmacist.
- First published
- 2026-10-26
- Last substantive update
- 2026-10-26
- How we research
- We started from our existing joint-formula summary, then re-read PubMed abstracts for every review, trial, case report and lab study cited, and read the NCCIH glucosamine and chondroitin and turmeric pages in full. The EFSA statement was read as a PubMed abstract only. Only abstracts were read for journal articles.
- How we rate evidence
- See "How we rate evidence" in the Evidence tab.
- Independence
- No product is promoted on this page. No brands or affiliate links are shown. Funding is flagged where the abstracts show it; most abstracts did not state it.
Sources 22
Each source was opened and checked. Where we read only the abstract, it says so. The small numbers in the text point here.
- Asthana C, Peterson GM, Shastri M, Patel RP. Development and validation of a novel high performance liquid chromatography-coupled with Corona charged aerosol detector method for quantification of glucosamine in dietary supplements. PLoS One. 2019. PMID 31059544. DOI 10.1371/journal.pone.0216039. (abstract)
- Brien S, Prescott P, Bashir N, Lewith H, Lewith G. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis Cartilage. 2008. PMID 18417375. DOI 10.1016/j.joca.2008.03.002. (abstract)
- Chen CS, Wen L, Yang F, et al.. Effects of dietary supplements on patients with osteoarthritis: A systematic review and network meta-analysis. J Integr Med. 2025. PMID 40425393. DOI 10.1016/j.joim.2025.04.008. (abstract)
- Clegg DO, Reda DJ, Harris CL, et al.. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006. PMID 16495392. DOI 10.1056/NEJMoa052771. (abstract)
- Dostrovsky NR, Towheed TE, Hudson RW, Anastassiades TP. The effect of glucosamine on glucose metabolism in humans: a systematic review of the literature. Osteoarthritis Cartilage. 2011. PMID 21251987. DOI 10.1016/j.joca.2011.01.007. (abstract)
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Statement on the safety of glucosamine for patients receiving coumarin anticoagulants. EFSA J. 2011. PMID 42015979. DOI 10.2903/j.efsa.2011.2473. (abstract)
- Forsyth JE, Nurunnahar S, Islam SS, et al.. Turmeric means "yellow" in Bengali: Lead chromate pigments added to turmeric threaten public health across Bangladesh. Environ Res. 2019. PMID 31550596. DOI 10.1016/j.envres.2019.108722. (abstract)
- Hochberg MC, Martel-Pelletier J, Monfort J, et al.. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2016. PMID 25589511. DOI 10.1136/annrheumdis-2014-206792. (abstract)
- Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. Pharmacotherapy. 2008. PMID 18363538. DOI 10.1592/phco.28.4.540. (abstract)
- Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ. Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis. Br J Sports Med. 2018. PMID 29018060. DOI 10.1136/bjsports-2016-097333. (abstract)
- Lombardi N, Crescioli G, Maggini V, et al.. Acute liver injury following turmeric use in Tuscany: An analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharmacol. 2021. PMID 32656820. DOI 10.1111/bcp.14460. (abstract)
- Lubis AMT, Siagian C, Wonggokusuma E, et al.. Comparison of Glucosamine-Chondroitin Sulfate with and without Methylsulfonylmethane in Grade I-II Knee Osteoarthritis: A Double Blind Randomized Controlled Trial. Acta Med Indones. 2017. PMID 28790224. (abstract)
- Mazurov VI, Belyaeva IB, Trofimov EA, et al.. Comparative efficacy of a combination of undenatured type II collagen, Boswellic acids, methylsulfonylmethane, vitamins C and D3 and a combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of primary osteoarthritis of the knee joint. Ter Arkh. 2023. PMID 38785054. DOI 10.26442/00403660.2023.12.202540. (abstract)
- Nakasone Y, Watabe K, Watanabe K, et al.. Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study. Exp Ther Med. 2011. PMID 22977594. DOI 10.3892/etm.2011.298. (abstract)
- National Center for Complementary and Integrative Health (US). NCCIH: Glucosamine and Chondroitin for Osteoarthritis: What You Need To Know (page last updated October 2023). NCCIH health information page. 2023. (full page)
- National Center for Complementary and Integrative Health (US). NCCIH: Turmeric: Usefulness and Safety (page last updated April 2025). NCCIH health information page. 2025. (full page)
- Papke DJ Jr, Viveiros K, Zota V, et al.. Turmeric supplement-associated hepatitis: a clinicopathological series of 11 cases highlighting pan-lobular and zone 3 injury. Histopathology. 2025. PMID 39381846. DOI 10.1111/his.15333. (abstract)
- Sawitzke AD, Shi H, Finco MF, et al.. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis. 2010. PMID 20525840. DOI 10.1136/ard.2009.120469. (abstract)
- Sumsuzzman DM, Khan ZA, Jung JH, et al.. Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis. J Clin Med. 2024. PMID 39685902. DOI 10.3390/jcm13237444. (abstract)
- Wang Z, Singh A, Jones G, et al.. Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr Rheumatol Rep. 2021. PMID 33511486. DOI 10.1007/s11926-020-00975-8. (abstract)
- Yokotani K, Nakanishi T, Chiba T, Sato Y, Umegaki K. Glucosamine and chondroitin sulfate do not enhance anticoagulation activity of warfarin in mice in vivo. Shokuhin Eiseigaku Zasshi. 2014. PMID 25212820. DOI 10.3358/shokueishi.55.183. (abstract)
- . Existing AlternativeMed joint-formula summary (read 2026-10-26). . . (summary-only)